Blood disorders
Lymphoma in Suzhou
苏州 淋巴瘤
2 hospitals in Suzhou
Order: papers led on lymphoma, 2021–2025, then A–Z. Research activity, not a rating of care.
Only hospitals listed for lymphoma: those with enough papers or registered trials on it in the records this site uses. Other hospitals in Suzhou may also treat it. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first.
- 48 papers led
- 10 papers led
Lymphoma in every city Suzhou on the disease page, with the national map
open trials on lymphoma with a hospital in Suzhou
Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 18 Nov 2026, with a listed hospital in Suzhou as lead sponsor or study site. 22 of them are led by a hospital in Suzhou. Check the registry for the current status. Whether someone can take part is decided by the study team.
Only trials registered on ClinicalTrials.gov are counted. Trials registered only in China’s own registry (ChiCTR) are not.
- RecruitingU69-CART-Cells For R/R T-ALL
- Phase
- Phase 1
- Started
- 2026-10
- Posted
- Registry
- NCT07350863
Age 15 years to 75 years (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingZeprumetostat, Azacitidine Combined With Lipo-MIT in R/R PTCL
- Phase
- Phase 2
- Started
- 2026-01
- Posted
- Registry
- NCT07372352
Age 18 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingGenetic Subtype-matched Targeted Therapy for the Treatment of Newly Diagnosed DLBCL With TP53 Mutation
- Phase
- Phase 2
- Started
- 2026-01
- Posted
- Registry
- NCT07499271
Age 18 years to 70 years (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingAn Open-label, Single-arm, Multicenter Phase II Clinical Study of Azacitidine, Chidamide Combined With PD-1 Monoclonal Antibody in the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma.
- Phase
- Early phase 1
- Started
- 2026-06
- Posted
- Registry
- NCT07598578
Age 18 years to 75 years (registered criteria)
Led by Second Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingA Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
- Phase
- Phase 1/Phase 2
- Started
- 2025-01
- Posted
- Registry
- NCT06697184
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesBeijing, Guangzhou, Suzhou
- RecruitingClinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma
- Phase
- Phase 2
- Started
- 2025-03
- Posted
- Registry
- NCT06854445
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 21 listed hospitals as study sitesChangsha, Dalian, Hangzhou, Harbin, Jinan, Lanzhou, Luzhou, Nanchang, Nanjing, Nanning, Shijiazhuang, Suzhou, Taiyuan, Wuhan, Wuhu, Xi'an, Xiamen, Zhengzhou
- RecruitingA Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Phase
- Phase 3
- Started
- 2025-09
- Posted
- Registry
- NCT06973187
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 24 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Dalian, Fuzhou, Harbin, Lanzhou, Luzhou, Nanchang, Nanning, Nantong, Ningbo, Shanghai, Shenyang, Shijiazhuang, Suzhou, Taiyuan, Wenzhou, Wuhan, Xi'an, Xining, Xuzhou, Zhengzhou
- RecruitingSelinexor, High-dose Methotrexate, and Rituximab Combined With Radiotherapy for Newly Diagnosed, Transplant-ineligible Patients With Central Nervous System Lymphoma: An Open-label, Single-arm, Multicenter Phase II Study
- Phase
- Phase 2
- Started
- 2025-06
- Posted
- Registry
- NCT07002099
Age 18 years to Not stated (registered criteria)
Led by Second Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingCombination Regimen of Teniposide, PD-1 Monoclonal Antibody and Selinixor for Patients With Relapsed or Refractory PCNSL
- Phase
- N/A
- Started
- 2025-01
- Posted
- Registry
- NCT07074470
Age 18 years to 75 years (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingA Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma
- Phase
- Phase 1/Phase 2
- Started
- 2025-07
- Posted
- Registry
- NCT07124936
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 19 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Hangzhou, Jinan, Kunming, Nanchang, Nanning, Shenyang, Suzhou, Taiyuan, Wuhan, Xi'an, Zhengzhou
- RecruitingVenetoclax Combined With Azacitidine, Chidamide, Vindesine, and Dexamethasone in Newly Diagnosed ETP-ALL Like Patients
- Phase
- Phase 2
- Started
- 2025-09
- Posted
- Registry
- NCT07159620
Age 14 years to 75 years (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingPA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma
- Phase
- Phase 2
- Started
- 2025-09
- Posted
- Registry
- NCT07188610
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 15 listed hospitals as study sitesBeijing, Chengdu, Guangzhou, Hangzhou, Hefei, Nanjing, Shanghai, Suzhou, Tianjin, Wuhan, Xuzhou, Zhengzhou
- RecruitingA Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
- Phase
- Phase 2
- Started
- 2025-11
- Posted
- Registry
- NCT07189065
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 38 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Dalian, Fuzhou, Guangzhou, Hangzhou, Hefei, Linyi, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Suzhou, Taiyuan, Tianjin, Wuhan, Xiamen, Xuzhou, Zhengzhou
- RecruitingPirtobrutinib, Lisaftoclax, and Rituximab in the Treatment of R/R DLBCL
- Phase
- Phase 2
- Started
- 2025-11
- Posted
- Registry
- NCT07255963
Age 18 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingZanubrutinib Combined With Rituximab in the Treatment of Secondary HLH in B-cell Lymphoma
- Phase
- Phase 4
- Started
- 2025-11
- Posted
- Registry
- NCT07270835
Age 14 years to 80 years (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingClinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies
- Phase
- Phase 1
- Started
- 2025-12
- Posted
- Registry
- NCT07284927
Age 18 years to 70 years (registered criteria)
Lead sponsor is not a listed hospital; 1 listed hospital as study siteSuzhou
- RecruitingOrelabrutinib as Consolidation and Maintenance Therapy in Treatment-Naïve MZL.
- Phase
- Phase 2
- Started
- 2025-10
- Posted
- Registry
- NCT07372365
Age 18 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingCMOP±R in the Treatment of Untreated Non-Hodgkin's Lymphoma
- Phase
- Phase 2
- Started
- 2024-07
- Posted
- Registry
- NCT06486337
Age 18 years to 75 years (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingEvaluate the Safety and Efficacy of Tafasitamab and Lenalidomide in Combination With Gemcitabine and Oxaliplatin Versus Rituximab in Combination With Gemcitabine and Oxaliplatin in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Phase
- Phase 3
- Started
- 2024-05
- Posted
- Registry
- NCT06521255
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 19 listed hospitals as study sitesBeijing, Changchun, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Jinan, Nanchang, Shanghai, Suzhou, Tianjin, Urumqi, Wenzhou, Wuhan, Zhengzhou
- RecruitingA Study of HDM2005 in Patients With Relapsed/Refractory B-cell Lymphoma and Advanced Solid Tumor
- Phase
- Phase 1
- Started
- 2024-08
- Posted
- Registry
- NCT06615193
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 8 listed hospitals as study sitesHangzhou, Jinan, Nanchang, Suzhou, Tianjin, Xuzhou, Zhengzhou
- RecruitingA Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
- Phase
- Phase 1/Phase 2
- Started
- 2024-11
- Posted
- Registry
- NCT06634589
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 4 listed hospitals as study sitesFuzhou, Hangzhou, Suzhou, Wenzhou
- RecruitingGlofitamab Bridging ASCT for Patients With Relapsed or Refractory DLBCL
- Phase
- Phase 2
- Started
- 2024-11
- Posted
- Registry
- NCT06682130
Age 18 years to 70 years (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingIntegrated Radiotherapy-optimized ASCT Sequential CAR-T Therapy for Patients With Relapsed and Refractory B-NHL
- Phase
- N/A
- Started
- 2024-12
- Posted
- Registry
- NCT07059741
Age 18 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingPomalidomide, Rituximab and Orelabrutinib Combined With Polatuzumab Vedotin in the Treatment of Newly Diagnosed Elderly Patients With DLBCL
- Phase
- N/A
- Started
- 2024-11
- Posted
- Registry
- NCT07072208
Age 70 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingBendamustine Combined With Chidamide and Lenalidomide for Relapsed and Refractory PTCL Patients
- Phase
- N/A
- Started
- 2024-11
- Posted
- Registry
- NCT07072221
Age 18 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingChidamide Combined With Brentuximab Vedotin Regimen for CD30+ PTCL Patients
- Phase
- N/A
- Started
- 2024-11
- Posted
- Registry
- NCT07074457
Age 18 years to 75 years (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- RecruitingClinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Phase
- Phase 1/Phase 2
- Started
- 2023-03
- Posted
- Registry
- NCT05768529
Age 18 years to 70 years (registered criteria)
Lead sponsor is not a listed hospital; 3 listed hospitals as study sitesChangsha, Shanghai, Suzhou
- RecruitingTreatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
- Phase
- Phase 1/Phase 2
- Started
- 2022-05
- Posted
- Registry
- NCT05294731
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 21 listed hospitals as study sitesBeijing, Bengbu, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Jinan, Nanchang, Nanjing, Qingdao, Shanghai, Suzhou, Taiyuan, Wenzhou, Wuhan, Zhengzhou
- RecruitingStudy of APG-2575 in Patients With Relapsed/Refractory CLL/SLL
- Phase
- Phase 2
- Started
- 2021-12
- Posted
- Registry
- NCT05147467
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 9 listed hospitals as study sitesGuangzhou, Haikou, Hangzhou, Nanchang, Suzhou, Wuhan, Zhengzhou
- RecruitingStudy of APG2575 Single Agent and Combination Therapy in Patients With Relapsed/Refractory CLL/SLL
- Phase
- Phase 1/Phase 2
- Started
- 2020-08
- Posted
- Registry
- NCT04494503
Age 18 years to Not stated (registered criteria)
Lead sponsor is not a listed hospital; 17 listed hospitals as study sitesBeijing, Changchun, Changsha, Chongqing, Guangzhou, Guiyang, Hangzhou, Nanchang, Nanjing, Nanning, Shanghai, Shijiazhuang, Suzhou, Tianjin, Wuhan
- RecruitingClinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma
- Phase
- Phase 2
- Started
- 2020-01
- Posted
- Registry
- NCT05182957
Age 18 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- Not yet recruitingU96-CAR-T-Cells For R/R B-ALL
- Phase
- Phase 1
- Started
- 2026-07
- Posted
- Registry
- NCT07511426
Age 18 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- Not yet recruitingA Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Phase
- Phase 2
- Started
- 2026-07
- Posted
- Registry
- NCT07599423
Age 18 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- Not yet recruitingPomalidomide Plus Anti-CD20 Antibody and Prednisone in Frontline Indolent B-Cell Lymphoma
- Phase
- Not given
- Started
- 2026-05
- Posted
- Registry
- NCT07609446
Age 18 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- Not yet recruitingSonrotoclax, Glofitamab, Gemcitabine, and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma
- Phase
- Phase 2
- Started
- 2026-08
- Posted
- Registry
- NCT07774234
Age 18 years to Not stated (registered criteria)
Led by First Affiliated Hospital of Soochow UniversitySuzhou
- Not yet recruitingA Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma
- Phase
- Phase 1/Phase 2
- Started
- 2026-09
- Posted
- Registry
- NCT07818499
Age 18 years to 75 years (registered criteria)
Lead sponsor is not a listed hospital; 2 listed hospitals as study sitesGuangzhou, Suzhou
- Not yet recruitingPlasma cfDNA Testing Guiding the Treatment Decisions of DLBCL
- Phase
- N/A
- Started
- 2024-02
- Posted
- Registry
- NCT06289959
Age 18 years to Not stated (registered criteria)
Led by Second Affiliated Hospital of Soochow UniversitySuzhou
Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.
Disease research in Suzhou
Each number is papers led on that disease, 2021–2025. “Open” counts open trials the hospital leads. Hospitals A–Z; this is not a ranking.
A blank cell means no papers or trials were found in these records. It does not mean the hospital does not treat that disease.
| Cancer | Blood disorders | Other diseases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital | Nasopharyngeal carcinoma | Oesophageal squamous cell carcinoma | Hepatocellular carcinoma | Stomach cancer | Lung cancer | Pancreatic cancer | Breast cancer | Glioma | Hepatoblastoma | Retinoblastoma | Chordoma | Osteosarcoma | Gastrointestinal stromal tumour | Neuroblastoma | Ewing sarcoma | Multiple myeloma | B-cell acute lymphoblastic leukaemia | Aplastic anaemia | Haemophagocytic lymphohistiocytosis | Lymphoma | Beta thalassaemia | Haemophilia A | Atypical haemolytic uraemic syndrome | Thrombotic thrombocytopenic purpura | Fanconi anaemia | Neuromyelitis optica spectrum disorder | IgG4-related disease | Myasthenia gravis | Moyamoya disease | Wilson disease | Biliary atresia | Coronary heart disease | Congenital heart disease | Scoliosis | Anti-NMDA receptor encephalitis | Takayasu arteritis | Hepatic echinococcosis | Idiopathic pulmonary fibrosis | Lymphangioleiomyomatosis | Amyotrophic lateral sclerosis | Spinal muscular atrophy | Fabry disease | Pompe disease | Duchenne muscular dystrophy | Behçet disease | Alport syndrome | IgA nephropathy | Gaucher disease | Niemann–Pick disease type C | Osteogenesis imperfecta | Primary biliary cholangitis | Primary sclerosing cholangitis | Congenital diaphragmatic hernia | Hirschsprung disease | Inherited epidermolysis bullosa | Hereditary angioedema | Familial adenomatous polyposis | Leber hereditary optic neuropathy | Majeed syndrome | NGLY1 deficiency | ISG15 deficiency | Shortlist |
| Affiliated Hospital of Soochow University太仓市第一人民医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | 0 | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Suzhou Hospital of Nanjing Medical University苏州市立医院 | none | 11 | 14 | 19 | 28 | none | none | none | none | none | none | 2 | 1 | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 7 | 13 | none | none | none | none | 1 | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Affiliated Zhangjiagang Hospital of Soochow University苏州大学附属张家港医院 | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | |
| Anhui Wanbei Coal-Electricity Group General Hospital皖北煤电集团总医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Changshu Hospital, Soochow University苏州大学附属常熟医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | 14 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Children's Hospital of Soochow University苏州大学附属儿童医院 | none | none | none | none | none | none | none | 11 | 1 | 1 | none | 2 | none | 16 | 1 | none | 3 | 4 | 5 | none | none | none | none | none | 0 | none | none | none | none | none | none | 6 | 3 | none | none | none | none | none | none | none | 0 | none | none | none | none | none | 1 | none | none | 1 | none | none | none | 3 | none | none | none | none | none | 0 | none | |
| First Affiliated Hospital of Soochow University苏州大学附属第一医院 | 8 | 22 | 73 | 902 open | 1861 open | 37 | 491 open | 71 | none | 2 | 2 | 4 | 6 | 1 | none | 277 open | 1210 open | 112 open | 62 open | 4819 open | 1 | 6 | none | 51 open | none | 10 | none | 9 | 3 | 2 | none | 17 | 5 | 3 | none | none | none | 3 | none | 1 | 0 | 3 | none | 2 | 0 | none | 2 | none | none | none | 2 | 1 | none | none | none | none | none | none | none | none | none | |
| Fourth Affiliated Hospital of Soochow University苏州大学附属第四医院(独墅湖医院) | none | 3 | none | none | none | none | none | 11 open | none | none | none | 1 | none | 1 | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | 1 | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Second Affiliated Hospital of Soochow University苏州大学附属第二医院 | 5 | 4 | none | 32 | 641 open | 11 | 271 open | 44 | none | none | none | 13 | 1 | none | 2 | 2 | none | none | none | 103 open | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | 0 | 1 | none | 1 | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | |
| Soochow Hopes Hematonosis Hospital苏州弘慈血液病医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Suzhou Hospital苏州市中西医结合医院 | none | none | none | none | none | none | none | none | none | none | none | 2 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Suzhou Hospital, Anhui Medical University宿州市立医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Suzhou Jiulong Hospital苏州九龙医院 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Suzhou Ninth People's Hospital苏州市第九人民医院 | none | none | none | 16 | none | none | none | none | none | none | none | 1 | 3 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Suzhou Tcm Hospital, Nanjing University of Tcm苏州市中医医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Suzhou Wujiang District Children's Hospital苏州市吴江区儿童医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Suzhou Xiangcheng People's Hospital苏州市相城人民医院 | none | none | none | none | none | none | none | none | none | none | none | 1 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Technology Town Hospital苏州科技城医院 | none | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
| Third Affiliated Hospital of Suzhou University苏州大学附属第三医院 | none | none | none | none | none | none | none | none | none | none | none | 0 | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | none | |
Column labels are short names. Choose one to open that disease in Suzhou.
- Glioma 11
- Hepatoblastoma 1
- Retinoblastoma 1
- Osteosarcoma 2
- Neuroblastoma 16
- Ewing sarcoma 1
- B-cell acute lymphoblastic leukaemia 3
- Aplastic anaemia 4
- Haemophagocytic lymphohistiocytosis 5
- Fanconi anaemia 0
- Coronary heart disease 6
- Congenital heart disease 3
- Spinal muscular atrophy 0
- IgA nephropathy 1
- Osteogenesis imperfecta 1
- Hirschsprung disease 3
- NGLY1 deficiency 0
- Nasopharyngeal carcinoma 8
- Oesophageal squamous cell carcinoma 22
- Hepatocellular carcinoma 73
- Stomach cancer 902 open
- Lung cancer 1861 open
- Pancreatic cancer 37
- Breast cancer 491 open
- Glioma 71
- Retinoblastoma 2
- Chordoma 2
- Osteosarcoma 4
- Gastrointestinal stromal tumour 6
- Neuroblastoma 1
- Multiple myeloma 277 open
- B-cell acute lymphoblastic leukaemia 1210 open
- Aplastic anaemia 112 open
- Haemophagocytic lymphohistiocytosis 62 open
- Lymphoma 4819 open
- Beta thalassaemia 1
- Haemophilia A 6
- Thrombotic thrombocytopenic purpura 51 open
- Neuromyelitis optica spectrum disorder 10
- Myasthenia gravis 9
- Moyamoya disease 3
- Wilson disease 2
- Coronary heart disease 17
- Congenital heart disease 5
- Scoliosis 3
- Idiopathic pulmonary fibrosis 3
- Amyotrophic lateral sclerosis 1
- Spinal muscular atrophy 0
- Fabry disease 3
- Duchenne muscular dystrophy 2
- Behçet disease 0
- IgA nephropathy 2
- Primary biliary cholangitis 2
- Primary sclerosing cholangitis 1
- Nasopharyngeal carcinoma 5
- Oesophageal squamous cell carcinoma 4
- Stomach cancer 32
- Lung cancer 641 open
- Pancreatic cancer 11
- Breast cancer 271 open
- Glioma 44
- Osteosarcoma 13
- Gastrointestinal stromal tumour 1
- Ewing sarcoma 2
- Multiple myeloma 2
- Lymphoma 103 open
- Fabry disease 0
- Duchenne muscular dystrophy 0
- Behçet disease 1
- IgA nephropathy 1
- Primary biliary cholangitis 0
Other cities nearby
Straight-line distance from the city centre; counts are hospitals listed for lymphoma.
Counts are listed hospitals only, not every hospital in each city.
Where these numbers come from
Papers
English-language PubMed papers, 2021–2025, where the first or last author lists the hospital first. Definitions
Trials
ClinicalTrials.gov records with the hospital as lead sponsor or site, as of 8 Nov 2026. Search Suzhou on ClinicalTrials.gov
Locations
Locations are shown at city centres. Check the hospital’s website for its address.